SSA Related Publication:
Anecdotally, via the Neuroendocrine Cancer UK Helpline and Natter S difficulties, since starting SSA treatment. Keeping a record of site of injection, dose received, date and any issu help optimise benefits of SSA treatment. Read patient experiences of SSAs and treatments HERE The article by Bouvier, Whyand & Davies was featured in the British Jo therapy, were experienced more frequently than previous clinical studi to read here Additional issues patients reported to the authors included: • Increased joint discomfort or pain • Hair thinning or loss (though rarely complete alopecia) • Weight loss or gain • Symptoms associated with vitamin deficiencies In 2018, our CEO Catherine Bouvier co-authored a publication on the patients prescribed somatostatin analogues.
Made with FlippingBook - Share PDF online